Jorge A Bezerra Selected Research

Biliary Atresia

10/2022	Maternal regulation of biliary disease in neonates via gut microbial metabolites.
1/2022	Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia.
1/2022	Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary Atresia.
10/2019	Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents.
5/2019	Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.
1/2019	Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome.
1/2019	Prospective Assessment of Ultrasound Shear Wave Elastography for Discriminating Biliary Atresia from other Causes of Neonatal Cholestasis.
1/2019	A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia.
12/2018	Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.
11/2018	Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge A Bezerra Research Topics

Disease

39	Biliary Atresia 10/2022 - 11/2002
14	Cholestasis 01/2022 - 10/2005
9	Liver Diseases (Liver Disease) 01/2020 - 02/2010
7	Fibrosis (Cirrhosis) 10/2019 - 09/2006
4	Portal Hypertension 01/2022 - 03/2007
4	End Stage Liver Disease 11/2020 - 08/2007
4	Infections 11/2018 - 11/2011
4	Jaundice (Icterus) 01/2017 - 11/2002
3	Inflammation (Inflammations) 10/2022 - 01/2015
3	Intrahepatic Cholestasis 12/2014 - 11/2002
2	Alagille Syndrome (Alagille-Watson Syndrome) 01/2022 - 12/2014
2	Disease Progression 12/2020 - 05/2010
2	Cholangiocarcinoma 05/2015 - 07/2014
2	Carcinogenesis 05/2015 - 07/2014
2	Rotavirus Infections 08/2009 - 07/2007
1	Disease Susceptibility (Diathesis) 10/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Sclerosing Cholangitis 01/2021
1	Ascites 12/2020
1	Cholangitis 12/2020
1	COVID-19 01/2020
1	Ciliopathies 01/2018
1	Neoplasms (Cancer) 05/2015
1	progressive familial intrahepatic 1 Cholestasis 12/2014
1	Avitaminosis (Vitamin Deficiency) 12/2014
1	Hyperplasia 07/2014
1	Neoplasm Metastasis (Metastasis) 07/2014
1	Virus Diseases (Viral Diseases) 10/2013

Drug/Important Bio-Agent (IBA)

10	BilirubinIBA 12/2020 - 12/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
5	CytokinesIBA 11/2018 - 05/2006
5	Interferon-gamma (Interferon, gamma)IBA 07/2007 - 11/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2015
3	Interleukin-33IBA 01/2019 - 07/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 05/2014
2	Biological ProductsIBA 10/2022 - 08/2005
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2014
2	AlbuminsIBA 12/2020 - 11/2020
2	Messenger RNA (mRNA)IBA 10/2019 - 02/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2010
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 12/2018 - 11/2017
2	SteroidsIBA 11/2018 - 05/2014
2	CollagenIBA 01/2018 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 05/2008
2	InterleukinsIBA 05/2015 - 04/2006
2	VitaminsIBA 12/2014 - 09/2012
2	Complementary RNA (cRNA)IBA 04/2004 - 11/2002
1	HypoxanthineIBA 10/2022
1	Butyrates (Butyrate)IBA 10/2022
1	Glutamine (L-Glutamine)FDA Link 10/2022
1	Glutamic Acid (Glutamate)FDA Link 10/2022
1	Keratin-7 (Cytokeratin 7)IBA 01/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022
1	maralixibatIBA 01/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Actins (F Actin)IBA 01/2022
1	CateninsIBA 01/2022
1	Aquaporin 1IBA 01/2022
1	Hepatocyte Nuclear Factor 1IBA 01/2022
1	somatostatin receptor 2IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2020
1	Alanine Transaminase (SGPT)IBA 11/2020
1	Transaminases (Aminotransferases)IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Glutathione (Reduced Glutathione)IBA 10/2019
1	TransferasesIBA 10/2019
1	AntioxidantsIBA 10/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2019
1	HLA-DR Antigens (HLA-DR)IBA 05/2019
1	InflammasomesIBA 11/2018
1	ChemokinesIBA 11/2018
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2017
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017
1	LigandsIBA 01/2017
1	Sulfamethoxazole FDA LinkGeneric 01/2017
1	Thymidine Monophosphate (TMP)IBA 01/2017
1	MitogensIBA 05/2015
1	TransposasesIBA 05/2015
1	Interleukin-8 (Interleukin 8)IBA 07/2014
1	Interleukin-13IBA 07/2014
1	nafamostatIBA 02/2014
1	Granzymes (Granzyme)IBA 02/2014
1	PerforinIBA 02/2014
1	MicroRNAs (MicroRNA)IBA 10/2013
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	MucinsIBA 10/2013
1	TubulinIBA 10/2013
1	Coloring Agents (Dyes)IBA 10/2013
1	Chromogranin AIBA 10/2013
1	tocophersolanIBA 09/2012

Therapy/Procedure

12	Liver Transplantation 10/2021 - 11/2002
7	Hepatic Portoenterostomy 05/2019 - 11/2007
6	Therapeutics 10/2019 - 09/2011
1	Injections 10/2019
1	Ligation 10/2013